Clinical sources and antimicrobial susceptibility of Prevotella timonensis at the university hospital of Montpellier, France

Salim Aberkane*, Baptiste Pradel, Yann Dumont, Alida C. M. Veloo, Chrislene Laurens, Lucas Bonzon, Sylvain Godreuil, Helene Marchandin, Helene Jean-Pierre

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    1 Citation (Scopus)


    We describe 84 clinical isolates of Prevotella timonensis recovered between January 2007 and November 2016 at the University Hospital of Montpellier. They were recovered from a variety of clinical samples, mostly of genital and wound origins. All isolates were isolated from a mixed aerobic and anaerobic microbiota. Antimicrobial susceptibility testing of 50 isolates showed 56% of beta-lactamase production and 40% of resistance to clindamycin. One strain was resistant to metronidazole. (C) 2018 Elsevier Ltd. All rights reserved.

    Original languageEnglish
    Pages (from-to)19-21
    Number of pages3
    Publication statusPublished - Apr-2018


    • Prevotella timonensis
    • France
    • Antimicrobial resistance
    • Clinical relevance
    • Anaerobic bacteria
    • NOV

    Cite this